← Back to Search

Dronabinol 2.5mg Cap for Postoperative Pain

Phase 4
Waitlist Available
Led By Jeffrey L Gum, MD
Research Sponsored by Jeffrey L Gum MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours post-operative
Awards & highlights

Study Summary

This trial found that patients who took Dronabinol daily used fewer opioids post-operatively than those who took a placebo.

Eligible Conditions
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours post-operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 72 hours post-operative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cumulative Morphine Milligrams at 72 hours post-operative
Secondary outcome measures
Cumulative Morphine Milligrams at 24 hours post-operative
Cumulative Morphine Milligrams at 48 hours post-operative
Worst pain in past 24 hours post-operative
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: DronabinolExperimental Treatment1 Intervention
2.5mg of oral Dronabinol daily starting with pre-op cocktail and continued twice daily for three days after surgery
Group II: PlaceboPlacebo Group1 Intervention
Capsule with placebo daily starting with pre-op cocktail and continued twice daily for three days after surgery

Find a Location

Who is running the clinical trial?

Jeffrey L Gum MDLead Sponsor
Jeffrey L Gum, MDPrincipal InvestigatorNorton Healthcare

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this clinical examination an option for me?

"This clinical trial is recruiting 90 individuals with postoperative pain ranging in age from 18 to 65. To be eligible, potential participants must fulfill the following conditions: No prior spine fusion surgery, between ages 18 and 65 years old, undergoing 1-3 level posterolateral fusions, opioid naive or not, willing and able to sign an informed consent form."

Answered by AI

In what other studies has Dronabinol 2.5mg Cap been effectively used?

"Presently, there are 38 ongoing studies concerning Dronabinol 2.5mg Cap with 6 of them in the concluding phase 3. Most tests for this drug are being conducted in Belmont, MA yet ninety diverse medical centres have taken up trials for Dronabinol 2.5mg Cap throughout the United States."

Answered by AI

Are there still slots available for recruitment in this trial?

"According to clinicaltrials.gov, this study is not accepting patients at the present time – it was first published on September 1st 2020 and last updated February 9th 2021. Nonetheless, there are currently 521 other medical trials actively enrolling volunteers."

Answered by AI

To what end is Dronabinol 2.5mg Cap typically administered?

"Dronabinol 2.5mg Cap is mainly utilized for weight loss, but it can also be prescribed to patients who have not responded adequately to conventional treatment and pharmacotherapy or those experiencing a diminished appetite."

Answered by AI

How many participants are expected to take part in this research?

"Unfortunately, this study is not actively seeking out new participants as of now. Originally posted on September 1st 2020 and last edited February 9th 2021, it appears to have closed its recruitment window for the time being. However, there are currently 483 studies related to pain post-operation in addition 38 trials pertaining to Dronabinol 2.5mg Capsule that are still enrolling patients."

Answered by AI

Are individuals below the age of 75 eligible for this research project?

"This clinical trial seeks participants who are of age and younger than 65 years old."

Answered by AI

Has the Dronabinol 2.5mg Cap received regulatory authorization from the FDA?

"We rate the safety of Dronabinol 2.5mg Cap a 3, as this is a Phase 4 trial meaning it has received regulatory approval."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Dronabinol for Post-operative Pain After Lumbar Fusion
Jeffrey L Gum MD 2020. "Dronabinol for Post-operative Pain After Lumbar Fusion". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04346407.
All > Cannabis
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top